Double-blind, placebo-controlled pilot trial of anthocyanin-rich purple sweet potato beverage on serum hepatic biomarker levels in healthy Caucasians with borderline hepatitis

Eur J Clin Nutr. 2017 Feb;71(2):290-292. doi: 10.1038/ejcn.2016.153. Epub 2016 Aug 17.

Abstract

The objective is to evaluate the efficacy of anthocyanin-rich purple-fleshed sweet potato (PSP) beverage on the serum levels of gamma-glutamyl transferase (GGT), aspartate aminotransferase (AST) and alanine aminotransferase (ALT) in healthy Caucasians with borderline hepatitis. Forty healthy Caucasians (41-69 years) consumed three bottles of the PSP beverage (177 mg anthocyanins per 125-ml bottle) or placebo (1.3 mg) per day for 8 weeks. Thirty-nine subjects completed the study and two subjects were excluded from statistical analysis. GGT levels in the PSP group on days 15 and 43 were lower (P=0.077 and 0.038, respectively), AST levels in the PSP group on days 29 and 43 were lower (P=0.010 and 0.045, respectively) and ALT level in the PSP group on day 43 was lower (P=0.037) than in the placebo group. The PSP beverage did not induce clinically relevant changes in other blood and clinical chemistry parameters.

Publication types

  • Randomized Controlled Trial

MeSH terms

  • Adult
  • Aged
  • Alanine Transaminase / blood
  • Anthocyanins / administration & dosage*
  • Aspartate Aminotransferases / blood
  • Beverages*
  • Biomarkers / blood
  • Double-Blind Method
  • Female
  • Healthy Volunteers
  • Hepatitis / blood*
  • Humans
  • Ipomoea batatas / chemistry*
  • Male
  • Middle Aged
  • Pilot Projects
  • White People
  • gamma-Glutamyltransferase / blood

Substances

  • Anthocyanins
  • Biomarkers
  • gamma-Glutamyltransferase
  • Aspartate Aminotransferases
  • Alanine Transaminase